Israel Englander Anixa Biosciences Inc Transaction History

Millennium Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$2.81 - $6.15 $47,913 - $104,863	17,051 Added 88.82%	36,249 $178,000
Q2 2022 Aug 15, 2022	SELL	$2.55 - $4.1 $12,696 - $20,413	-4,979 Reduced 20.59%	19,198 $59,000
Q1 2022 May 16, 2022	BUY	$2.5 - $3.42 $21,162 - $28,950	8,465 Added 53.88%	24,177 $66,000
Q4 2021 Feb 14, 2022	BUY	$2.88 - $5.5 $45,250 - $86,416	15,712 New	15,712 $47,000
Q3 2020 Nov 16, 2020	SELL	$1.79 - $3.3 $70,354 - $129,703	-39,304 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.53 - $3.06 $60,135 - $120,270	39,304 New	39,304 $120,000

5.56M

21K

6.7K

Ticker ANIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,661,700
Market Cap $107M
Description
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.